GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) » Definitions » Inventories, Raw Materials & Components

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Inventories, Raw Materials & Components : £0.00 Mil (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Inventories, Raw Materials & Components?

Oxford Cannabinoid Technologies Holdings's inventories, raw materials & components for the quarter that ended in Oct. 2023 was £0.00 Mil.


Oxford Cannabinoid Technologies Holdings Inventories, Raw Materials & Components Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Inventories, Raw Materials & Components Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Inventories, Raw Materials & Components
- - - - -

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only - - - - -

Oxford Cannabinoid Technologies Holdings Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Headlines

No Headlines